Syncona (SYNC) Share Price, News & Analysis

Company Overview

Syncona's purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams. Our balance sheet underpins our strategy, enabling us to take a long-term view as we look to improve the lives of patients with no or poor treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders.

Key Stats

• Today's Range: 93.10 to 94
• 50-Day Range: 86.90 to 97
• 52-Week Range: 79.60 to 102.60
• Volume: 190,273 shs
• Average Volume: 684,066 shs
• Market Capitalization: £567.49 million
• P/E Ratio: N/A
• Dividend Yield: 1.04%
• Price Target: GBX 189
• Consensus Rating: Buy

Syncona Stock Analysis - MarketRank™

Syncona scored higher than 33% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Syncona has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.

Upside Potential

Syncona has a consensus price target of GBX 189, representing about 102.6% upside from its current price of GBX 93.30.

Amount of Analyst Coverage

Syncona has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Syncona is -6.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Syncona is -6.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Syncona has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for SYNC.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Syncona pays a meaningful dividend of 1.04%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Syncona does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Syncona this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Syncona insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.75% of the stock of Syncona is held by insiders.

Percentage Held by Institutions

22.46% of the stock of Syncona is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:SYNC
• Previous Symbol: LON:BACT
• CIK: N/A
• Web: www.bacitltd.com
• Phone: 17168531362
• Fax: N/A
• Employees: 1,208
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Syncona: GBX 189
• High Price Target: GBX 189
• Low Price Target: GBX 189
• Potential Upside/Downside: +101.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX (15.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£16.90 million
• Net Margins: -145.42%
• Pretax Margin: N/A
• Return on Equity: -9.02%
• Return on Assets: 0.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.02
• Quick Ratio: 0.53

Sales & Book Value

• Annual Sales: -£14.05 million
• Price / Sales: -40.56
• Cash Flow: GBX 79.78 per share
• Price / Cash Flow: 1.17
• Book Value: GBX 177.06 per share
• Price / Book: 0.53

Miscellaneous

• Outstanding Shares: 608,193,000
• Free Float: N/A
• Market Cap: £569.88 million
• Optionable: Not Optionable
• Beta: 0.31